Nanomaterial-directed, photothermal ablation is a practical future approach for the treatment of early-stage bladder cancer. Using a new PEGylation technique with bi-functional nitrophenyl carbonate PEG (bi-NPC-PEG) that promotes uniform suspension of the nanomaterial in solution, we have shown that gold nanorods conjugated to an anti-EGFR antibody (nano-EGFR) bind effectively to EGFR-expressing bladder cancer cells. The subsequent application of infrared light, specifically tuned to the plasmon resonance of the nanorods used in this work, allows for the specific heating of nano-EGFR to the point of localized cellular death. Such an approach, administering nano-EGFR intravesically via a urinary catheter and infrared light via a modified cystoscope, represents a novel, future clinical application of this technology, which avoids the problem of systemic exposure and clearance of nanoparticles from body.
INTRODUCTION
Thanks to the strong surface plasmon resonance, biocompatibility, and available techniques for synthesis and bioconjugation, gold nanomaterials have attracted much interest for their application in biology and medicine. 1 Gold, like many other metals, supports surface plasmon which is a combined excitation of free electrons and electromagnetic wave. Since surface plasmon is confined to the surface of the metal, the nature and frequency of the resonance strongly depends on the geometry, especially at the nanoscale. This has naturally led to a proliferation of various shapes and geometries including spherical nanoparticle, 2 nanorod, 3 nanoshell, 4 nanocage, 5 nanorose, 6 and nanooctahedra. 7 For many biomedical applications, there is great interest in shifting the surface plasmon resonance into the near-infrared region where the background tissue absorption and potential off-target toxicity from the laser energy is minimal. For this reason, gold nanorods, nanoshells and nanocages have been the most studied nanoscale geometries in this setting. Among * Author to whom correspondence should be addressed.
Email: won.park@colorado. these, nanoshells tend to exhibit higher scattering, making them an effective contrast agent for optical imaging, while nanorods and nanocages exhibit strong absorption and thus are better candidates for photothermal therapy. 8 9 In this paper, we use a bioconjuagted gold nanorod, absorbing strongly in the near-infrared region, to demonstrate targeted photothermal treatment of bladder cancer.
A key enabling technology required for successful biomedical application of plasmonic nanomaterial is bioconjugation. Several methods have been reported for immobilization of targeting moieties on the surface of a gold nanorod. Direct attachment of antibodies to gold nanorods has been reported in which the antibodies were physically adsorbed onto either bare or poly(styrene sulfonate) coated nanorods. 10 11 However, proteins immobilized directly onto solid surfaces tend to undergo alterations of conformation and functionality due to microenvironment influences. For this reason, tethering targeting molecules on to the free end of poly(ethylene glycol) (PEG) has become a widely accepted method. Proteins tethered on nanoparticles and nanorods via PEG experience less steric hindrance and are therefore expected to react more efficiently with complimentary biomolecules than those immobilized directly or with short linkers. Modifying the nanomaterial surface with PEG, a process often referred to as PEGylation, has added benefits of improving the water solubility of nanomaterials without the toxic surfactant commonly used in the synthesis process, reducing immunogenic reaction, and consequently improving circulation in vivo. [12] [13] [14] Even without further modification, the long circulation time of PEGylated nanomaterials administered systemically leads to preferential accumulation in tumors by enhanced permeability and retention (EPR) effect. 12 15 The PEGylated nanomaterials have been tethered with targeting entities such as antibodies, lectins, folic acid and other small molecules. 10 11 16-20 These nanomaterials will then selectively interact with tumor cells that express targeted features on the cell membranes and could also lead to more efficient uptake by the cells. [16] [17] [18] [19] [20] [21] [22] In this paper, we report a new PEGylation technique to produce gold nanorods with amine-reactive free ends, which can be used to subsequently bind with proteins. The new technique uses bi-functional nitrophenyl carbonate (bi-NPC-PEG). NPC readily binds with any biomolecules with primary amine group (e.g., coupling proteins, small peptides, lectins). Therefore, using gold nanorods prefunctionalized with bi-NPC-PEG allows bioconjugation of amine groups without any additional modifications. Bi-NPC-PEG derivatives are commercially available and thus present themselves as cost effective alternative to purchasing or synthesizing hetero-functional PEG derivatives.
Treatment of superficial bladder cancer with nanoroddirected, photothermal ablation addresses an area of ongoing clinical need. Bladder cancer is common, with more than 73,000 cases expected in the United States in 2012. 23 Most cases present as superficial (non-muscle invasive) disease and are treated medically with intravesical Bacillus Calmette-Guerin (BCG), administered directly into the bladder. Despite BCG use, recurrent bladder cancer is frequent and patients may progress from superficial to an advanced, life-threatening stage at the time of recurrence. 24 One unique opportunity in the treatment of superficial bladder cancer is the ability to directly deliver medical therapy to the cancer cells via a urinary catheter, with minimal risk of systemic exposure of the nanomaterials delivered in such a manner. This approach therefore minimizes, if not eliminates, the accumulation of nanomaterials in unintended organs and the question of clearance of nanomaterials from body after treatment, a concern which has been raised with the systemic use of nanoparticles. In seeking a differentially-expressed surface marker for nanomaterial targeting in bladder cancer, the epidermal growth factor receptor (EGFR) is a good candidate as it is noted to be frequently over-expressed on bladder cancer cells, but is uncommonly observed on the normal urothelium. [25] [26] [27] Clinically, photothermal laser irradiation could be delivered to patients treated with intravesical, nanoparticle-directed therapy with minimal modification to currently utilized fiber optic cystoscopes in generalized clinical use.
MATERIALS AND METHODS

Materials
Monomethoxy PEG thiol (mPEG-SH, MW2000), bifunctional PEG-nitrophenyl carbonate (bi-NPC-PEG, MW2000), and hetero-functional caboxymethol PEG thiol (HS-PEG-COOH MW3400) were purchased from Laysan Bio (Arab, AL). Dubelco phosphate buffered saline (PBS), 3,4-dihydroxyl L-phenylalanine (DOPA), N -(3-Dimethylaminopropyl)-N -ethylcarbodiimide hydrochloride (EDAC), cetyltrimethylammonium bromide (CTAB), sodium borohydrate (NaBH 4 )HAuCl 4 ·3H 2 O were obtained from Sigma (St. Louis, MO). Cetuximab (C225) 2 mg/mL, was manufactured by ImClone system Incorporated, (Brabchburg, NJ).
Preparation of Gold Nanorods
Gold nanorod was prepared by seed-mediated growth method. [28] [29] [30] The seed solution was first prepared in a 15 mL centrifuge tube, with 0. M of ascorbic acid. After gentle inversion several times, the mixture was allowed to set overnight. Next, the suspension of gold nanorods was set in a warm water bath at 40 C for 20 min and then centrifuged at 8,750 G for 20 min. After decantation, 50 mL of water was added to re-suspend the nanorods, which were subsequently centrifuged and decanted again, before the final concentration of the nanorods was adjusted to be ∼ 3 mM.
Preparation of Amine-Reactive PEG-Modified Nanorod and Antibody Conjugation For PEGylation with bi-NPC-PEG, 1 mL of 3 mM gold nanorod solution was mixed with 1 mL of 1, 2, or 4 mg/mL of mPEG-SH and 1 mg/mL DOPA in 0 1× PBS buffer and gently reverted on a nutator overnight. Gold nanorods were then washed with water by three cycles of centrifugation at 7,500 G for 20 min and decanted before being re-suspended in 0.5 mL water. Subsequently, it was mixed with 100 mg/mL of bi-NPC-PEG (MW2000) in 0.5 mL water and nutated overnight. Sample purification was done through three cycles of centrifugation at 7,500 G for 20 minutes each. After final centrifugation process the PEGylated gold nanorods were re-dispersed in 1 mL of water.
The first PEGylation process with mPEG-SH allows nanorods to stabilize in water and provide sufficient spacing between the nanorods during the second PEGylation process. The use of bi-NPC-PEG instead of heterofunctional PEG with two different binding groups makes the initial PEGylation process essential because without sufficient spacing between the nanorods, bi-NPC-PEG can link the nanorods together, causing irreversible agglomeration. At the same time, too high a concentration of mPEG-SH could crowd out bi-NPC-PEG and thus it is important to find the optimal concentrations of mPEG-SH and bi-NPC-PEG. The PEGylated nanorods were then conjugated with C-225, a recombinant, human/mouse chimeric monoclonal antibody to epidermal growth factor receptor ( EGFR). Gold nanorod solution was first centrifuged at 10,000 G for 5 min. and decanted. Subsequently, the gold nanorods were re-suspended in 500 L PBS containing 2 mg/mL C-225. The mixture was set on a nutator at 4 C overnight. After the addition of 1.5 mL PBS containing 0.05% (v/v) Tween20, the conjugated nanorods were washed for six cycles with centrifugation at 12,000 G for 5 min, decanted and re-suspended in PBS-containing 0.05% Tween20. The schematic of the PEGylation and antibody conjugation process is provided in Figure 1 . Antibody conjugated nanorods were well suspended in solution and no further sonication was necessary to re-suspend the nanorod bioconjugates after vigorous centrifugation, indicating PEGylation and antibody conjugation were done successfully. For comparison's sake, we also prepared gold nanorod bioconjugates using two conventional methods found in the literature. First, antibody was directly attached to the nanorod following El-Sayed et al. 31 Additionally, following Eck et al. 32 antibody conjugation by HS-PEG-COOH was carried out as follows. 1 mL of 3 mM gold nanorod solution was mixed with either HS-PEG-COOH (10% w/v) only or 80:20 mixture of mPEG-SH and HS-PEG-COOH (10% w/v for the mixture), and set on nutator overnight. The PEGylated gold nanorods were washed with water by three cycles of centrifugation at 7,500 G for 20 min and decantation. They are finally re-suspended in 1 mL water. Then, 0.5 mL of PEGylated gold nanorod solution was mixed with 0.5 mL of 0.1 M MES buffer (pH 4.5). The mixture was then combined with 40 mg of EDAC in a microcentrifuge tube. After 30 min. of incubation at room temperature, nanorods were centrifuged and decanted and resuspended in 2 mL water. After this, the same procedure described above for C-225 conjugation was carried out. Stability Test of PEGylated Nanorods For accelerated testing of colloidal stability, we conducted repeated steps of centrifugation and redispersion for bioconjugates prepared by the three techniques-direct attachment, HS-PEG-COOH, and bi-NPC-PEG. All samples were centrifuged at 12,000 G for 5 min, decanted, sonicated for 5 min, and redispersed by pipetting.
Cell Binding Assay and Photothermal Ablation
For cell binding assay, HTB9 (American Type Culture Collection, Manassas, VA, USA) and primary bladder culture were grown in OptiMEM (Gibco, Grand Island, NY, USA) with 3.75% fetal bovine serum (Gemini, Woodland, CA, USA) and 100 units streptomycin-penicillin sulphate (Life Technologies, Grand Island, NY, USA) in 96 well plates or chamber slides. Cells were incubated at 37 C with 5% CO 2 . On the next day, cells were incubated with EGFR conjugated gold nanorods for two hours, and then the medium was removed and washed three times with PBS. The cells were then fixed with 2% formalin and probed with DyLight ™ labeled secondary antibody against human IgG (Jackson lab). The binding of the gold nanorods and C-225 were detected by fluorescent microscope (Nikon Eclipse TE2000-S) where the green fluorescence from the secondary antibody was monitored.
For the thermal ablation experiments, HTB-9 cells were seeded in 24-well plates and treated with C-225 conjugated gold nanorods or C-225 only as control for two hours. This treatment time was selected to mimic the longest intravesical treatment that is tolerated in humans. The treatment media was then removed; the cells were washed once with 1 mL PBS, before 200 L of PBS was added prior to the laser treatment, with an additional 1 mL of medium added immediately after the laser treatment. Cells were placed back in the CO 2 incubator for 2 hours, before being stained with neutral red or trypan blue. Fiber-coupled diode laser (DILAS) emitting at 808 nm was used in thermal ablation experiments. The spot size was approximately 5 mm 2 and the cells were exposed at (1) 
RESULTS AND DISCUSSION
With the method described in Section 2.2, a high yield with uniform size distribution was achieved, as shown in the scanning electron micrograph (SEM) in Figure 2 (a). The nanorod exhibited strong surface plasmon resonance, but due to their asymmetric shape, there were two distinct resonances: transverse resonance at a shorter wavelength and longitudinal resonance at a longer wavelength. As shown in Figure 2 (b), the extinction is dominated by the longitudinal plasmon occurring in the near-infrared region. The position of the extinction peak may be tuned by the aspect ratio of the nanorod. In this study, we tuned our gold nanorods to exhibit strong plasmon resonance at around 800 nm, a wavelength that should have little effect on normal tissue, in concordance with the output of the laser used for photothermal ablation experiments described later. For the subsequent bioconjugation processes and also for the photothermal therapy, it is essential to control the concentration of gold nanorods accurately and reliably. For this purpose, we carefully calibrated the gold nanorod concentrations using inductively coupled plasma mass spectrometry (ICP-MS) and compared the measured gold concentrations with the peak optical extinction value. As shown in Figure 3 , we obtained a linear relationship between the gold nanorod concentrations and peak optical extinction over a decade. Each symbol in this figure represents a different sample synthesized and characterized independently. The observed results attest to the reproducibility of our synthesis process. After this relationship was established, all gold nanorod concentrations were calibrated against this curve.
Optical extinction spectra were taken for nanorods before and after PEGylation to verify that the PEGylation process had not compromised the optical properties. As shown in Figure 4 , optical extinction spectra were well preserved after PEGylation. PEGylated nanorods exhibited a strong absorption peak at around 800 nm, while the assynthesized nanorods exhibited plasmon resonance peak at 808 nm. The small differences in the absorption peak position were attributed to the effect of coating. The side faces of as-synthesized nanorods are known to be covered with CTAB bilayer which forces gold to grow into a rod shape during the synthesis process. The CTAB bilayer is typically 4-5 nm thick and the index of refraction of CTAB is 1.435. After several centrifugation steps, some of the CTAB bilayer coating was removed from the nanorod surface. The elimination of the higher index coating layer resulted in a small blue shift in the optical extinction spectrum, as shown in Figure 4 . Upon PEGylation, the nanorods were again covered with organic molecules with a refractive index higher than that of water and thus the extinction peak exhibited a red shift. The difference in the peak absorbance between individual samples was due to small variations in nanorod concentrations. Other than the variations in amplitudes, the optical spectra of the PEGylated samples were nearly identical to the original spectrum of as-synthesized nanorods, indicating that the PEGylation process was reliable and reproducible, without a large degree of agglomeration, which would have caused significant distortion in the extinction spectrum. Conjugation with antibody C-225 was performed and the functionalized gold nanorods ( EGFR-AuNR) were tested for cell binding capacity. Figure 5 shows the fluorescence micrographs of formalin fixed untreated HTB9 conducted. Metallic nanostructures exhibiting plasmon resonance generally show strongly enhanced absorption and scattering. While we chose the dimensions of gold nanorods in such a way that they exhibit strong absorption, a desired characteristic for photothermal ablation therapy, scattering is not completely eliminated. Numerical simulations using finite element method showed that for the nanorods used in this study the total optical extinction was made of 72% absorption and 28% scattering. The light scattering by gold nanorods provides additional contrast in dark-field microscopy. Figure 6 (b) compared to the control in Figure 6 (a), similarly to the observations by El-Sayed et al. 33 To further distinguish the light scattering due to EGFR-AuNR from the scattering due to cell membranes, a 715 nm long pass filter (FGL715S, Thorlabs) was inserted to filter out all visible light. For near-infrared light, the cell membranes should scatter little while gold nanorods scatters strongly due to the plasmon resonance at 800 nm. As a result, clearly differentiated images in Figures 6(c) and (d) were obtained. The control sample produced a dark image due to little scattering while bright scattered light was collected in the EGFRAuNR treated sample. These results combined with binding assay results clearly demonstrate that gold nanorods were successfully conjugated with EGFR and the resultant EGFR-AuNRs were successfully attached to bladder Before proceeding with the thermal ablation experiments, we compared the new bioconjugation process with the conventional techniques, comparing the stability and binding efficiencies. First, for accelerated testing of colloidal stability, we conducted repeated steps of centrifugation and redispersion for the bioconjugates prepared by the three techniques: direct attachment, COOH-PEG and bi-NPC-PEG. Details of the protocols are given in Section 2.3. The sample prepared by direct attachment yielded precipitates that were impossible to redisperse by sonication and pipetting. As shown in Figures 7(a)-(d) , the original solution exhibited the characteristic purple color due to the plasmon resonances of gold nanorods. As more centrifugations were performed, serially displayed from Figures 7(a) to (d) , the solution color became gradually clearer will less purple coloration, indicating loss of gold nanorods. After the third centrifugation, all nanorods were precipitated and solution became completely clear. On the other hand, the bioconjugates prepared by COOH-PEG and bi-NPC-PEG exhibited better stability. In both of these cases, even after repeated centrifugations, the conjugates were readily redispersed in water with 5 minutes of sonication and pipetting. As shown in Figures 7(a)-(d) , the solutions remain purple after repeated centrifugations, indicating good dispersion of gold nanorods.
Since the direct attachment approach showed poor stability, the binding efficiency was tested only for the PEG-COOH samples. The binding assay was conducted in exactly the same way as described in Section 2.5. As shown in Figure 7 (e), the PEG-COOH samples did show membrane binding but the fluorescence signal was weak overall compared to the bi-NPC-PEG sample shown in Figure 7 (f). Also, there were many visually apparent "speckles" in the PEG-COOH samples, indicative of non-specifically bound aggregates of gold. These results show the new conjugation method using bi-NPC-PEG provides both higher stability and more effective membrane binding compared to the conventional techniques previously described in the literature. After the successful binding was confirmed, thermal ablation experiments were conducted by irradiating cells treated with EGFR-AuNR and those with C-225 (as control) with fiber-coupled laser emitting at 808 nm focused to an area of 5 mm 2 . We conducted two sets of experiments in which laser power and laser exposure duration were varied respectively. To test for cell viability after laser treatment, we used trypan blue staining. In the laser power variation experiments, the laser power density was varied from 20 W/cm 2 to 90 W/cm 2 while the exposure time was fixed at 1 minute. In the control samples treated with C-225 only, no cell death was observed until the power density was increased to 90 W/cm 2 , the highest level used in these experiments. In contrast, samples treated with EGFRAuNR showed clear trypan blue staining, indicating cell death, at laser power level as low as 20 W/cm 2 . The area of blue stained region increased with increasing laser power, indicating greater cell death. Figure 7 shows images of trypan blue stained cells irradiated with two different laser powers. As shown, no blue region was observed in the control sample treated with laser power of 50 W/cm 2 while the EGFR-AuNR treated sample showed a large blue stained area under the same laser irradiation conditions. Also, at 90 W/cm 2 , the highest laser power investigated in this study where the control sample showed a small blue region representing non-specific cellular killing, the EGFR-AuNR treated sample showed much greater blue region, clearly demonstrating much more effective cell killing. Some samples showed concentric rings of trypan blue dyed cells and empty regions in between the concentric rings due to detachment of dead cells which was confirmed through optical microscopy. Brightfield images of outer boundary of trypan blue dyed region in Figure 8 confirm the existence of acellular region between trypan blue dyed areas. Due to the chromatic aberration of single objective lens and the lack of contrast in black-and-white CCD camera, the trypan blue staining isn't clearly observable in regular images but upon intentionally offsetting the focus (Fig. 8(f) ) cell death boundary becomes clear as dead cells go out of focus (due to membrane destruction) while live cells are still in focus. This technique allowed us to precisely measure the areas of cell death, which were used to quantitatively assess the effectiveness of photothermal therapy as a function of laser power and duration.
The area of trypan blue stained region was estimated by image analysis software (ImageJ, National Institute of Health, Bethesda, MD) for cell death quantification. To minimize and quantify errors in area estimation, eight separate measurements were made for each stained region. The plot in Figure 9 (a) shows the laser power dependence of cell death. Cell death area for EGFR-AuNR treated cells showed a sharp increase starting at 40 W/cm 2 and saturated at powers greater than 80 W/cm 2 . Control samples did not show any cell death until the power reached 90 W/cm 2 . Considering non-specific cell death due to high laser power at 90 W/cm 2 and also the saturation behavior where the cell death area stops increasing at 80 W/cm 2 , the laser power for the most efficient cell death is 80 W/cm 2 for 1 minute exposure. In the second set of experiments in which the laser power was fixed at 20 W/cm 2 while the exposure time was varied from 30 seconds to 3 minutes, no cell death was observed in control samples treated with C-225 while samples treated with EGFR-AuNR showed a similar behavior to that observed in the power dependence. As depicted in Figure 9 (b), cell death area showed a sharp increase between 1 and 2 minutes and saturated at longer exposure times. Thermal ablation should depend not only on the total energy delivered by the laser but also on the heat capacity of the cells and dissipation by the environment. Therefore, the actual laser power density and duration for effective cell killing should be different for different samples or settings. However, our experimental results do show that our EGFR-AuNR construct enables highly efficient and selective cell killing. Additionally, we showed that the efficacy of photothermal therapy is a function of laser treatment conditions and thus a careful optimization is needed for the most effective therapy.
CONCLUSIONS
We have developed a new bioconjugation technique for gold nanorod using a bi-functional nitrophenyl carbonate-PEG (bi-NPC-PEG) that requires no further modification for EGFR attachment. It was shown by cell binding assay and darkfield microscopy that EGFR-AuNRs produced by this technique forms stable suspension in water and exhibits effective binding with EGFR-expressing bladder cancer cells. In fact, optical microscopy showed that EGFR-AuNR remained attached to HTB9 cells after repeated washing processes. Furthermore, upon comparing with conventional methods, bi-NPC-PEGylated AuNRs showed excellent stability and efficient binding. It was also demonstated that the application of infrared light, specifically tuned to the plasmon resonance of the nanorods, allows for the heating of EGFR-AuNR to the point of localized cellular death. The laser treatment was highly specific in that the laser alone did not damage the cells unless exceptionally high power was used. This demonstrated the highly targeted nature of the EGFR-AuNR therapy. Clinical application of this technology can be accomplished with minimal modifications of current clinical practices by administering EGFR-AuNR intravesically via a urinary catheter and infrared light via a cystoscope. It is also important to note that this clinical approach avoids the problem of systemic exposure and clearance of nanoparticles from body. Nanomaterialdirected, photothermal ablation is therefore a rational and practical future approach for the treatment of early-stage bladder cancer.
